Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10
Endocyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Endocyte Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Kyzeo Imaging Enters into Agreement with Endocyte 12
Endocyte Enters into Agreement Seattle Children’s Research Institute 13
Licensing Agreements 14
Endocyte Receives Rights from Radiomedix 14
Endocyte Enters into Licensing Agreement with ABX 15
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 16
Equity Offering 17
Endocyte Raises USD201.2 Million in Public Offering of Shares 17
Endocyte Raises USD86.3 Million in Public Offering of Shares 18
Endocyte Plans to Raise up to USD150 Million in Public Offering of Securities 19
Endocyte Raises Funds through Private Placement of Shares and Warrants 20
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Endocyte Completes Public Offering Of Shares For US$108.7 Million 22
Acquisition 23
Novartis to Acquire Endocyte 23
Endocyte Inc – Key Competitors 25
Endocyte Inc – Key Employees 26
Endocyte Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Jul 31, 2018: Endocyte provides second quarter 2018 financial results and operational update 28
May 09, 2018: Endocyte Provides First Quarter 2018 Financial Results and Operational Update 30
Nov 06, 2017: Endocyte Reports Third Quarter Financial Results 32
Aug 08, 2017: Endocyte Reports Second Quarter Financial Results and Provides Clinical and Pipeline Update 34
May 10, 2017: Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update 36
Mar 10, 2017: Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update 38
Corporate Communications 40
Mar 15, 2018: Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments 40
Feb 27, 2018: Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors 41
Feb 21, 2017: Endocyte Appoints Michael T. Andriole as Chief Financial Officer 42
Product News 43
10/17/2017: New Potential Treatment for Prostate Cancer Receives Boost 43
09/06/2017: Endocyte Presents Data at the 2017 CAR-TCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR T-Cell Therapy 44
04/16/2018: Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018 45
Clinical Trials 46
Sep 05, 2017: Endocyte Announces Presentation at the European Society for Medical Oncology 46
Jun 02, 2017: Endocyte Announces Clinical Update for EC1169 47
May 26, 2017: Endocyte to Announce Updated Data on clinical-stage asset EC1169 at the 2017 American Society of Clinical Oncology Annual Meeting 48
Other Significant Developments 49
Oct 03, 2018: Endocyte becomes first Purdue startup to reach $1.5B in value 49
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
Endocyte Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10
Endocyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kyzeo Imaging Enters into Agreement with Endocyte 12
Endocyte Enters into Agreement Seattle Children's Research Institute 13
Endocyte Receives Rights from Radiomedix 14
Endocyte Enters into Licensing Agreement with ABX 15
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 16
Endocyte Raises USD201.2 Million in Public Offering of Shares 17
Endocyte Raises USD86.3 Million in Public Offering of Shares 18
Endocyte Plans to Raise up to USD150 Million in Public Offering of Securities 19
Endocyte Raises Funds through Private Placement of Shares and Warrants 20
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Endocyte Completes Public Offering Of Shares For US$108.7 Million 22
Novartis to Acquire Endocyte 23
Endocyte Inc, Key Competitors 25
Endocyte Inc, Key Employees 26
Endocyte Inc, Other Locations 27
List of Figures
Endocyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10